GW PHARMACEUTICALS PLC Net Income
GW PHARMACEUTICALS PLC reported Net Income of -$19.68 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2021-05-03
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for the quarter ending 2021-03-31 was -$19.68M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for the quarter ending 2020-12-31 was -$29.15M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for the quarter ending 2020-09-30 was -$12.19M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for the quarter ending 2020-06-30 was -$8.83M, a 111.07% decline year-over-year.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for fiscal 2020 was -$58.13M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for fiscal 2019 was -$9.02M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for fiscal 2018 was -$295.17M.
- GW PHARMACEUTICALS PLC net income (loss) attributable to parent for fiscal 2017 was -$170.46M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$19.68M 10-Q · filed 2021-05-03 | -$48.82M derived: sum of 2 quarters · filed 2021-05-03 | -$61.01M derived: sum of 3 quarters · filed 2021-05-03 | -$69.84M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-12-31 | -$29.15M 10-K · filed 2021-02-26 | -$41.34M derived: sum of 2 quarters · filed 2021-02-26 | -$50.16M derived: sum of 3 quarters · filed 2021-02-26 | -$58.13M 10-K · filed 2021-02-26 |
| 2020-09-30 | -$12.19M 10-K · filed 2021-02-26 | -$21.02M derived: sum of 2 quarters · filed 2021-02-26 | -$28.98M 10-Q · filed 2020-11-05 | -$53.93M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-06-30 | -$8.83M 10-K · filed 2021-02-26 | -$16.79M 10-Q · filed 2020-08-07 | -$41.74M derived: sum of 3 quarters · filed 2021-05-03 | -$55.50M derived: sum of 4 quarters · filed 2021-05-03 |
| 2020-03-31 | -$7.96M 10-Q · filed 2021-05-03 | -$32.91M derived: sum of 2 quarters · filed 2021-05-03 | -$46.67M derived: sum of 3 quarters · filed 2021-05-03 | $33.08M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$24.95M 10-K · filed 2021-02-26 | -$38.70M derived: sum of 2 quarters · filed 2021-02-26 | $41.05M derived: sum of 3 quarters · filed 2021-02-26 | -$9.02M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$13.76M 10-K · filed 2021-02-26 | $65.99M derived: sum of 2 quarters · filed 2021-02-26 | $15.93M 10-Q · filed 2020-11-05 | -$55.98M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $79.75M 10-K · filed 2021-02-26 | $29.68M 10-Q · filed 2020-08-07 | -$42.22M derived: sum of 3 quarters · filed 2021-02-26 | -$122.10M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$50.06M 10-K · filed 2021-02-26 | -$121.97M derived: sum of 2 quarters · filed 2021-02-26 | -$201.85M derived: sum of 3 quarters · filed 2021-02-26 | -$285.86M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$71.91M 10-K · filed 2021-02-26 | -$151.78M derived: sum of 2 quarters · filed 2021-02-26 | -$235.80M derived: sum of 3 quarters · filed 2021-02-26 | -$305.26M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-09-30 | -$79.88M 10-K · filed 2020-02-27 | -$163.89M derived: sum of 2 quarters · filed 2020-02-27 | -$233.35M 10-Q · filed 2019-11-06 | -$295.17M 10-K · filed 2021-02-26 |
| 2018-06-30 | -$84.01M 10-K · filed 2020-02-27 | -$153.47M 10-Q · filed 2019-08-07 | -$215.29M derived: sum of 3 quarters · filed 2021-02-26 | -$269.14M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-03-31 | -$69.46M 10-K · filed 2020-02-27 | -$131.28M derived: sum of 2 quarters · filed 2021-02-26 | -$185.13M derived: sum of 3 quarters · filed 2021-02-26 | -$237.78M derived: sum of 4 quarters · filed 2021-02-26 |
| 2017-12-31 | -$61.82M 10-K · filed 2021-02-26 | -$115.67M derived: sum of 2 quarters · filed 2021-02-26 | -$168.32M derived: sum of 3 quarters · filed 2021-02-26 | -$211.58M derived: sum of 4 quarters · filed 2021-02-26 |
| 2017-09-30 | -$53.85M 10-KT · filed 2019-02-28 | -$106.50M derived: sum of 2 quarters · filed 2019-02-28 | -$149.77M derived: sum of 3 quarters · filed 2019-02-28 | -$170.46M 10-K · filed 2020-02-27 |
| 2017-06-30 | -$52.65M 10-KT · filed 2019-02-28 | -$95.91M derived: sum of 2 quarters · filed 2019-02-28 | -$116.61M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2017-03-31 | -$43.27M 10-KT · filed 2019-02-28 | -$63.96M derived: sum of 2 quarters · filed 2019-02-28 | ||
| 2016-12-31 | -$20.69M 10-KT · filed 2019-02-28 | |||
| 2016-09-30 | -$91.70M 10-KT · filed 2019-02-28 |